0001179110-19-003511.txt : 20190307
0001179110-19-003511.hdr.sgml : 20190307
20190307160401
ACCESSION NUMBER: 0001179110-19-003511
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190305
FILED AS OF DATE: 20190307
DATE AS OF CHANGE: 20190307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDSTEIN MICHAEL
CENTRAL INDEX KEY: 0001043027
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 19665846
MAIL ADDRESS:
STREET 1: 3 EAST 84 STREET
CITY: NEW YORK
STATE: NY
ZIP: 10028
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2019-03-05
0
0001477449
Teladoc Health, Inc.
TDOC
0001043027
GOLDSTEIN MICHAEL
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
1
0
0
0
Common Stock
2019-03-05
4
M
0
20500
8.71
A
21418
D
Common Stock
2019-03-05
4
S
0
10500
63.33
D
10918
D
Common Stock
2019-03-05
4
S
0
10000
63.47
D
918
D
Stock Option (right to buy)
8.71
2019-03-05
4
M
0
20500
0.00
D
2025-02-25
Common Stock
20500
13105
D
Represents the weighted average price of transactions ranging from $63.25 to $63.61. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
Represents the weighted average price of transactions ranging from $63.39 to $63.56. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
The option vested as to 25% of the shares on February 25, 2016. The remainder of the shares vested in 36 equal monthly installments thereafter.
/s/ Adam C. Vandervoort, attorney-in-fact
2019-03-07